A detailed history of Swiss National Bank transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Swiss National Bank holds 6,016,700 shares of BMY stock, worth $347 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares
6,016,700
Previous 6,000,800 0.26%
Holding current value
$347 Million
Previous $249 Million 24.94%
% of portfolio
0.21%
Previous 0.17%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$39.66 - $51.75 $630,594 - $822,825
15,900 Added 0.26%
6,016,700 $311 Million
Q2 2024

Aug 08, 2024

SELL
$40.25 - $52.99 $3.73 Million - $4.91 Million
-92,700 Reduced 1.52%
6,000,800 $249 Million
Q1 2024

May 07, 2024

SELL
$47.98 - $54.4 $21.1 Million - $23.9 Million
-439,100 Reduced 6.72%
6,093,500 $330 Million
Q4 2023

Feb 06, 2024

SELL
$48.48 - $57.85 $10.9 Million - $13 Million
-224,700 Reduced 3.33%
6,532,600 $335 Million
Q3 2023

Nov 08, 2023

SELL
$57.89 - $64.73 $48.6 Million - $54.3 Million
-839,100 Reduced 11.05%
6,757,300 $392 Million
Q2 2023

Aug 09, 2023

SELL
$63.71 - $70.74 $53.6 Million - $59.5 Million
-841,500 Reduced 9.97%
7,596,400 $486 Million
Q1 2023

May 10, 2023

SELL
$65.71 - $74.53 $15.8 Million - $17.9 Million
-240,400 Reduced 2.77%
8,437,900 $585 Million
Q4 2022

Feb 08, 2023

SELL
$68.48 - $81.09 $37.6 Million - $44.5 Million
-548,557 Reduced 5.95%
8,678,300 $624 Million
Q3 2022

Nov 09, 2022

SELL
$0.13 - $76.84 $29,692 - $17.6 Million
-228,400 Reduced 2.42%
9,226,857 $656 Million
Q2 2022

Aug 09, 2022

SELL
$72.62 - $79.98 $11.5 Million - $12.7 Million
-158,600 Reduced 1.65%
9,455,257 $728 Million
Q1 2022

May 09, 2022

BUY
$61.48 - $73.72 $71.8 Million - $86.1 Million
1,167,700 Added 13.83%
9,613,857 $702 Million
Q4 2021

Feb 08, 2022

SELL
$53.63 - $62.52 $20.8 Million - $24.2 Million
-387,000 Reduced 4.38%
8,446,157 $527 Million
Q3 2021

Nov 08, 2021

SELL
$59.17 - $69.31 $17.9 Million - $21 Million
-302,600 Reduced 3.31%
8,833,157 $523 Million
Q2 2021

Aug 06, 2021

BUY
$61.91 - $67.42 $20.5 Million - $22.4 Million
331,869 Added 3.77%
9,135,757 $610 Million
Q1 2021

May 07, 2021

BUY
$59.34 - $66.74 $10.7 Million - $12 Million
180,500 Added 2.09%
8,803,888 $556 Million
Q4 2020

Feb 05, 2021

SELL
$57.74 - $65.43 $17 Million - $19.2 Million
-293,700 Reduced 3.29%
8,623,388 $535 Million
Q3 2020

Nov 09, 2020

SELL
$57.43 - $63.64 $6.94 Million - $7.69 Million
-120,900 Reduced 1.34%
8,917,088 $538 Million
Q2 2020

Aug 05, 2020

SELL
$54.82 - $64.09 $9.63 Million - $11.3 Million
-175,600 Reduced 1.91%
9,037,988 $531 Million
Q1 2020

May 08, 2020

BUY
$46.4 - $67.43 $79.8 Million - $116 Million
1,718,900 Added 22.93%
9,213,588 $514 Million
Q4 2019

Feb 06, 2020

BUY
$49.21 - $64.19 $98.1 Million - $128 Million
1,992,824 Added 36.22%
7,494,688 $481 Million
Q3 2019

Nov 12, 2019

BUY
$42.77 - $50.71 $3.47 Million - $4.12 Million
81,194 Added 1.5%
5,501,864 $279 Million
Q2 2019

Aug 02, 2019

SELL
$44.62 - $49.34 $5.36 Million - $5.93 Million
-120,100 Reduced 2.17%
5,420,670 $246 Million
Q1 2019

May 10, 2019

BUY
$45.12 - $53.8 $6.59 Million - $7.86 Million
146,100 Added 2.71%
5,540,770 $264 Million
Q4 2018

Feb 13, 2019

BUY
$48.76 - $63.23 $4.15 Million - $5.38 Million
85,100 Added 1.6%
5,394,670 $280 Million
Q3 2018

Nov 08, 2018

SELL
$55.19 - $62.25 $10 Million - $11.3 Million
-181,600 Reduced 3.31%
5,309,570 $330 Million
Q2 2018

Aug 09, 2018

BUY
$50.53 - $62.98 $7.4 Million - $9.23 Million
146,500 Added 2.74%
5,491,170 $304 Million
Q1 2018

May 04, 2018

SELL
$59.92 - $68.98 $47.2 Million - $54.3 Million
-787,700 Reduced 12.84%
5,344,670 $338 Million
Q4 2017

Feb 07, 2018

BUY
$59.94 - $65.35 $2.45 Million - $2.67 Million
40,900 Added 0.67%
6,132,370 $376 Million
Q3 2017

Nov 03, 2017

BUY
$55.23 - $63.74 $336 Million - $388 Million
6,091,470
6,091,470 $388 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Swiss National Bank Portfolio

Follow Swiss National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.